NTRK1 and Glucose intolerance: Targeted deletion of vascular NGF or β-cell TrkA impairs GSIS and provokes glucose intolerance, whereas exogenous NGF enhances GSIS in human islets without elevating basal insulin output [88] (Figure 2).